JPMorgan Chase & Co. Lowers Cellebrite DI (NASDAQ:CLBT) Price Target to $25.00
Cellebrite DI (NASDAQ:CLBT – Free Report) had its target price cut by JPMorgan Chase & Co. from $29.00 to $25.00 in a research report sent to investors on Monday morning,Benzinga reports. They currently have an overweight rating on the stock. A number of other research firms have also weighed in on CLBT. Needham & Company […]
Cellebrite DI (NASDAQ:CLBT – Free Report) had its target price cut by JPMorgan Chase & Co. from $29.00 to $25.00 in a research report sent to investors on Monday morning,Benzinga reports. They currently have an overweight rating on the stock. A number of other research firms have also weighed in on CLBT. Needham & Company […]
